This Comprehensive Final Exam – Oncology 2026/2027 is a detailed 37-page examination study resource containing multiple-choice, true/false, clinical scenario and treatment-based questions with correct answers. The material provides broad oncology coverage, beginning with female reproductive cancers such as ovarian, cervical, endometrial, vaginal and vulvar cancers before progressing into breast cancer, male reproductive cancers, head and neck malignancies, lung cancer, gastrointestinal cancers, bone and soft-tissue tumors, melanoma, Hodgkin lymphoma and pediatric oncology. It integrates cancer epidemiology, etiology, histopathology, tumor grading and staging with diagnostic, therapeutic and radiation-oncology concepts. Comprehensive Final Exam
The breast and gynecologic oncology sections review cervical cancer staging, Pap testing, squamous cell carcinoma, ovarian and endometrial malignancies, gynecologic radiation treatment and breast-conserving surgery. Breast cancer questions address invasive ductal carcinoma, phyllodes tumors, tumor markers, tamoxifen, chemotherapy, tumor size and staging, metastatic patterns, lumpectomy, mastectomy and external-beam radiation techniques. The material also includes questions on prostate and testicular cancer and their radiation-treatment considerations. Comprehensive Final Exam
A substantial portion concentrates on radiation oncology and head and neck cancer. Students review radiation dose concepts, tissue tolerance, treatment fields, immobilization, spinal-cord tolerance, treatment complications and the effects of radiation on normal structures. Head and neck topics include squamous cell carcinoma, oral-cavity cancer, laryngeal and nasopharyngeal tumors, lymphatic drainage, cranial-nerve involvement, dental preparation before radiation therapy, concurrent chemotherapy, leukoplakia and osteoradionecrosis. Lung oncology questions cover smoking and occupational risk factors, metastasis, hemoptysis and radiation-associated pneumonitis. Comprehensive Final Exam
The later sections extend into gastrointestinal, musculoskeletal, skin and hematologic oncology, including esophageal and liver malignancies, osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, nephroblastoma, melanoma, Merkel cell tumors and classical Hodgkin lymphoma. Clinical vignettes require students to connect pathology and staging findings with management concepts. The final pages address pediatric radiation oncology, secondary malignancy risk, age-appropriate communication, adolescent privacy, psychosocial support during cancer treatment and radiation field-size calculations. Comprehensive Final Exam
This resource is therefore especially relevant to Radiation Therapy/Radiologic Technology students, oncology students, radiation oncology trainees, nursing and allied-health students studying cancer care, and students preparing for comprehensive oncology or radiation-therapy final examinations. The uploaded document does not identify a university, institution, or specific course code, so these details should not be invented for the title. Comprehensive Final Exam
Keywords: comprehensive oncology final exam 2026, oncology final exam 2027, oncology exam questions and answers, radiation oncology exam, radiation therapy exam questions, cancer staging questions, breast cancer exam questions, cervical cancer staging, ovarian cancer questions, prostate cancer questions, testicular cancer, head and neck cancer exam, lung cancer questions, gastrointestinal oncology, esophageal cancer questions, osteosarcoma questions, Ewing sarcoma, rhabdomyosarcoma, melanoma exam questions, Hodgkin lymphoma questions, pediatric oncology, radiation therapy complications, external beam radiation therapy, EBRT questions, tumor grading and staging, cancer epidemiology, cancer etiology, oncology clinical scenarios, radiologic technology oncology, radiation therapy final exam, cancer treatment questions
Content preview
Comprehensive Final Exam-
Oncology 2026/2027 Exam
Questions and Correct
Answers | New Update
Cancers of which female reproductive organ is most deadly?
Ovarian
Uterus (endometrium)
Vaginal
Vulvar - ANSWER ✔✔Ovarian
Cervical cancer which has spread outside the cervix to the upper third of
the vagina is which stage?
I
,II
III
IV - ANSWER ✔✔II
Chlamydia infections are a risk factor for developing which female
reproductive cancer?
Ovarian
Vulvar
Vaginal
Falopian tube - ANSWER ✔✔Vulvar
Overall, cervical cancer occurs most frequently with those associated
with which of the factors below?
Women with lower socioeconomic status
Early sexual activity and multiple partners
Multiple instances of pelvic infection
A&B
A&C
B&C
A, B & C - ANSWER ✔✔A, B, & C
,PAP testing is a screening tool used to detect which cancer?
Ovarian
Cervical
Vaginal
Vulvar - ANSWER ✔✔Cervical
Which is the most common histological form of cervical cancer?
Squamous cell carcinoma
adenocarcinoma
Epithelial
Germ cell - ANSWER ✔✔SCC
Which female reproductive organ is most likely to develop cancer?
Ovarian
Uterus (endometrial)
Vaginal
Vulvar - ANSWER ✔✔Uterus (endometrial)
A total dose greater than 7000 cGy in fractions of 180 cGy is used to
treat which male reproductive cancer?
3
COPYRIGHT©JOSHCLAY 2026/2027. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, Prostate
Testicle
Left seminal vesicle
all of the above - ANSWER ✔✔Prostate
A total dose of 2500 to 3500 cGy in fractions of 150-160 cGy is used to
treat which male reproductive cancer?
Penis
Testicle
Prostate
Bladder - ANSWER ✔✔Testicle
Lumpectomy is the surgery of choice for women with early stage breast
cancer.
True
False - ANSWER ✔✔True
Men with Klinefelter's syndrome are at a greater risk of developing
breast cancer than the general populace.
True
False - ANSWER ✔✔True